
### [NCIT:C7190](http://purl.obolibrary.org/obo/NCIT_C7190)
**Label:** Malignant Hypopharyngeal Neoplasm

**Subclasses:** [NCIT:C133003](http://purl.obolibrary.org/obo/NCIT_C133003) (Hypopharyngeal Carcinoma by AJCC v8 Stage), [NCIT:C133006](http://purl.obolibrary.org/obo/NCIT_C133006) (Stage II Hypopharyngeal Carcinoma AJCC v8), [NCIT:C133007](http://purl.obolibrary.org/obo/NCIT_C133007) (Stage III Hypopharyngeal Carcinoma AJCC v8), [NCIT:C133005](http://purl.obolibrary.org/obo/NCIT_C133005) (Stage I Hypopharyngeal Carcinoma AJCC v8), [NCIT:C8533](http://purl.obolibrary.org/obo/NCIT_C8533) (Stage IV Hypopharyngeal Carcinoma AJCC v6), [NCIT:C8038](http://purl.obolibrary.org/obo/NCIT_C8038) (Stage I Hypopharyngeal Carcinoma AJCC v6), [NCIT:C8236](http://purl.obolibrary.org/obo/NCIT_C8236) (Recurrent Hypopharyngeal Squamous Cell Carcinoma), [NCIT:C8039](http://purl.obolibrary.org/obo/NCIT_C8039) (Stage II Hypopharyngeal Carcinoma AJCC v6 and v7), [NCIT:C8234](http://purl.obolibrary.org/obo/NCIT_C8234) (Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C8235](http://purl.obolibrary.org/obo/NCIT_C8235) (Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C9101](http://purl.obolibrary.org/obo/NCIT_C9101) (Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C8232](http://purl.obolibrary.org/obo/NCIT_C8232) (Stage I Hypopharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C9465](http://purl.obolibrary.org/obo/NCIT_C9465) (Hypopharyngeal Carcinoma), [NCIT:C8233](http://purl.obolibrary.org/obo/NCIT_C8233) (Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8040](http://purl.obolibrary.org/obo/NCIT_C8040) (Stage III Hypopharyngeal Carcinoma AJCC v6), [NCIT:C133008](http://purl.obolibrary.org/obo/NCIT_C133008) (Stage IV Hypopharyngeal Carcinoma AJCC v8), [NCIT:C6028](http://purl.obolibrary.org/obo/NCIT_C6028) (Metastatic Malignant Neoplasm in the Hypopharynx), [NCIT:C4043](http://purl.obolibrary.org/obo/NCIT_C4043) (Hypopharyngeal Squamous Cell Carcinoma), [NCIT:C91251](http://purl.obolibrary.org/obo/NCIT_C91251) (Hypopharyngeal Carcinoma by AJCC v7 Stage), [NCIT:C6048](http://purl.obolibrary.org/obo/NCIT_C6048) (Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C9353](http://purl.obolibrary.org/obo/NCIT_C9353) (Recurrent Malignant Hypopharyngeal Neoplasm), [NCIT:C9241](http://purl.obolibrary.org/obo/NCIT_C9241) (Recurrent Hypopharyngeal Carcinoma), [NCIT:C90524](http://purl.obolibrary.org/obo/NCIT_C90524) (Hypopharyngeal Carcinoma by AJCC v6 Stage), [NCIT:C89047](http://purl.obolibrary.org/obo/NCIT_C89047) (Stage IV Hypopharyngeal Carcinoma AJCC v7), [NCIT:C89046](http://purl.obolibrary.org/obo/NCIT_C89046) (Stage III Hypopharyngeal Carcinoma AJCC v7), [NCIT:C89045](http://purl.obolibrary.org/obo/NCIT_C89045) (Stage I Hypopharyngeal Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- [UBERON:0001051](http://purl.obolibrary.org/obo/UBERON_0001051) (hypopharynx) 75.00%
- Thing 51.13%
- [UBERON:0013522](http://purl.obolibrary.org/obo/UBERON_0013522) (subdivision of tube) 32.72%
- [UBERON:0000064](http://purl.obolibrary.org/obo/UBERON_0000064) (organ part) 28.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.24%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.37%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 26.73%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 26.67%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 26.62%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 26.52%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 26.52%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 26.42%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 26.42%
- CP:0000037 0.00%


